logo

Cornbread Hemp

“Fastest-Growing CBD Brand in America”

Cannabis

Company Information

Cornbread Hemp is the fastest-growing cannabidiol (CBD) brand in America.

This company was co-founded by Jim Higdon, who grew up in the small town that served as the headquarters for the “Cornbread Mafia” — a group of Kentucky men who created the largest domestic marijuana production operation in U.S. history during the 1980s.

It was this background that led Higdon to publish a nonfiction account of his hometown in 2012, a book whose success launched him into a journalism career. While reporting on the 2018 Farm Bill that would re-legalize hemp, Higdon realized that there were no companies making authentic, high-quality CBD products.

So he decided to start such a company with his cousin. And in 2019, Cornbread Hemp was born.

Two years after launching, this company reached two million dollars in revenue. And in 2022, revenue grew to five-and-a-half million dollars, while margins on its products reached ninety percent. Cornbread Hemp also acquired a hemp processing company to vertically integrate its business. Now it’s seeking additional capital to keep growing.

The market for Cornbread’s products is growing significantly. The CBD market in general is projected to reach fifty-five billion dollars by 2028.

According to a recent study, only five percent of CBD brands are USDA certified organic. That puts Cornbread Hemp in a prestigious group. More than fifty percent of the company’s monthly revenues come from return customers, many of whom have left five-star reviews. For example:

“Stop looking for another brand to try, these are the best.”

“I have tried several different CBD oils… but Cornbread exceeded my expectations.”

As mentioned, Cornbread is the fastest-growing CBD brand in America — growing 300% year-over-year.

This year, the company projects to generate twelve million dollars in net revenue, with projections reaching thirty million dollars in 2024 and nearly fifty million dollars in 2025.

Team Background

Co-Founder & CCO: Jim Higdon

Co-Founder & CEO: Eric Zipperle

Pharmaceutical Advisor: Dr. Leslie Mudd